Trinity Biotech: Aris Kekedjian
Trinity Biotech has appointed Aris Kekedjian its CEO, effective Oct. 3. He succeeds Trinity cofounder Ronan O'Caoimh, who will remain on the company's board. Kekedjian also is becoming the firm's chairman. He has more than 30 years of global business leadership and was most recently president and CEO of Icahn Enterprises, senior advisor to ECN Capital, and independent director at companies including Xerox, Finserv Acquisition, and XPO Logistics. He also spent 30 years at General Electric and was most recently its chief investment officer and global head of business development.